Sanuwave Health Price to Sales Ratio 2012-2025 | SNWV
Historical PS ratio values for Sanuwave Health (SNWV) over the last 10 years. The current P/S ratio for Sanuwave Health as of January 16, 2026 is .
| Sanuwave Health P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2026-01-15 | 27.75 | 4.81 | |
| 2025-09-30 | 37.48 | $5.77 | 6.50 |
| 2025-06-30 | 32.86 | $7.45 | 4.41 |
| 2025-03-31 | 35.37 | $8.28 | 4.27 |
| 2024-12-31 | 23.00 | $9.05 | 2.54 |
| 2024-09-30 | 11.93 | $10.05 | 1.19 |
| 2024-06-30 | 6.00 | $9.19 | 0.65 |
| 2024-03-31 | 8.08 | $10.22 | 0.79 |
| 2023-12-31 | 4.88 | $10.79 | 0.45 |
| 2023-09-30 | 7.91 | $11.19 | 0.71 |
| 2023-06-30 | 8.51 | $11.86 | 0.72 |
| 2023-03-31 | 15.75 | $10.54 | 1.49 |
| 2022-12-31 | 8.55 | $10.36 | 0.83 |
| 2022-09-30 | 21.56 | $9.69 | 2.22 |
| 2022-06-30 | 28.50 | $9.61 | 2.97 |
| 2022-03-31 | 52.50 | $10.04 | 5.23 |
| 2021-12-31 | 63.75 | $9.30 | 6.86 |
| 2021-09-30 | 45.00 | $8.66 | 5.20 |
| 2021-06-30 | 67.20 | $7.31 | 9.19 |
| 2021-03-31 | 63.75 | $5.34 | 11.94 |
| 2020-12-31 | 69.38 | $4.01 | 17.29 |
| 2020-09-30 | 80.63 | $2.22 | 36.38 |
| 2020-06-30 | 98.44 | $1.25 | 78.95 |
| 2020-03-31 | 75.00 | $1.82 | 41.30 |
| 2019-12-31 | 60.00 | $2.05 | 29.28 |
| 2019-09-30 | 58.09 | $2.57 | 22.61 |
| 2019-06-30 | 51.93 | $3.68 | 14.13 |
| 2019-03-31 | 75.94 | $4.13 | 18.37 |
| 2018-12-31 | 86.25 | $4.63 | 18.64 |
| 2018-09-30 | 73.13 | $4.34 | 16.85 |
| 2018-06-30 | 163.80 | $3.32 | 49.40 |
| 2018-03-31 | 195.38 | $2.48 | 78.71 |
| 2017-12-31 | 90.75 | $1.97 | 46.04 |
| 2017-09-30 | 63.75 | $3.36 | 18.99 |
| 2017-06-30 | 42.19 | $3.75 | 11.26 |
| 2017-03-31 | 48.75 | $4.18 | 11.65 |
| 2016-12-31 | 65.59 | $5.11 | 12.84 |
| 2016-09-30 | 56.25 | $5.06 | 11.11 |
| 2016-06-30 | 15.38 | $5.09 | 3.02 |
| 2016-03-31 | 19.54 | $5.76 | 3.39 |
| 2015-12-31 | 24.38 | $5.67 | 4.30 |
| 2015-09-30 | 42.75 | $5.31 | 8.05 |
| 2015-06-30 | 71.25 | $6.13 | 11.63 |
| 2015-03-31 | 48.75 | $6.54 | 7.45 |
| 2014-12-31 | 65.63 | $6.66 | 9.86 |
| 2014-09-30 | 78.75 | $8.65 | 9.10 |
| 2014-06-30 | 198.75 | $8.71 | 22.81 |
| 2014-03-31 | 254.63 | $9.63 | 26.44 |
| 2013-12-31 | 210.00 | $11.77 | 17.84 |
| 2013-09-30 | 255.00 | $10.47 | 24.35 |
| 2013-06-30 | 251.25 | $11.91 | 21.10 |
| 2013-03-31 | 341.25 | $12.89 | 26.47 |
| 2012-12-31 | 60.00 | $13.62 | 4.41 |
| 2012-09-30 | 110.63 | $15.35 | 7.21 |
| 2012-06-30 | 112.50 | $15.06 | 7.47 |
| 2012-03-31 | 150.00 | $14.29 | 10.50 |
| 2011-12-31 | 97.50 | $15.84 | 6.16 |
| 2011-09-30 | 1012.50 | $17.03 | 59.46 |
| 2011-06-30 | 1248.75 | $22.40 | 55.76 |
| 2011-03-31 | 2062.50 | $22.91 | 90.01 |
| 2010-12-31 | 1601.25 | $21.37 | 74.92 |
| 2010-09-30 | 937.50 | $19.89 | 47.13 |
| 2010-06-30 | 1537.50 | $16.15 | 95.19 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.238B | $0.033B |
| SANUWAVE Health, Inc. is engaged in the development and commercialization of non-invasive, biological response-activating devices for the repair and regeneration of tissue, musculoskeletal and vascular structures. The Company's product candidates include its proprietary PACE technology applicable in wound healing, orthopedic/spine, plastic/cosmetic and cardiac conditions; and dermaPACE for treatment of the skin and subcutaneous soft tissue. The Company's products help in activating biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, helping to restore the body's normal healing processes and regeneration. SANUWAVE Health, Inc. is based in Alpharetta, USA. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $214.803B | 24.76 |
| EssilorLuxottica (ESLOY) | France | $151.023B | 0.00 |
| Stryker (SYK) | United States | $138.625B | 27.52 |
| Boston Scientific (BSX) | United States | $133.464B | 30.52 |
| Medtronic (MDT) | Ireland | $126.919B | 17.58 |
| Medline (MDLN) | United States | $56.109B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.167B | 0.00 |
| Agilent Technologies (A) | United States | $41.059B | 25.95 |
| ResMed (RMD) | United States | $38.047B | 26.33 |
| GE HealthCare Technologies (GEHC) | United States | $37.585B | 17.98 |
| Koninklijke Philips (PHG) | Netherlands | $29.051B | 18.98 |
| Terumo (TRUMY) | Japan | $20.817B | 23.43 |
| Insulet (PODD) | United States | $20.154B | 62.55 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.589B | 10.97 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.974B | 0.00 |
| Baxter (BAX) | United States | $10.471B | 8.45 |
| Sunny Optical Technology (SNPTF) | China | $9.589B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.688B | 31.24 |
| Demant (WILYY) | Denmark | $7.372B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $4.338B | 13.22 |
| BillionToOne (BLLN) | United States | $4.335B | 0.00 |
| Envista Holdings (NVST) | United States | $4.060B | 23.29 |
| ICU Medical (ICUI) | United States | $3.829B | 24.31 |
| Haemonetics (HAE) | United States | $3.464B | 15.42 |
| Prestige Consumer Healthcare (PBH) | United States | $3.155B | 14.39 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.099B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.403B | 15.45 |
| Perrigo (PRGO) | Ireland | $2.088B | 5.23 |
| AtriCure (ATRC) | United States | $2.061B | 0.00 |
| Neogen (NEOG) | United States | $2.058B | 45.05 |
| LeMaitre Vascular (LMAT) | United States | $1.962B | 39.50 |
| Curaleaf Holdings (CURLF) | Canada | $1.846B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.715B | 75.18 |
| Phibro Animal Health (PAHC) | United States | $1.624B | 16.22 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.459B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.441B | 20.86 |
| Kestra Medical Technologies (KMTS) | United States | $1.341B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.178B | 349.57 |
| Capricor Therapeutics (CAPR) | United States | $1.099B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.090B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.944B | 0.00 |
| InMode (INMD) | Israel | $0.888B | 10.04 |
| Omeros (OMER) | United States | $0.866B | 0.00 |
| Valneva SE (VALN) | France | $0.865B | 0.00 |
| CeriBell (CBLL) | United States | $0.847B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.581B | 15.75 |
| Cerus (CERS) | United States | $0.526B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.494B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.486B | 0.00 |
| Brainsway (BWAY) | Israel | $0.452B | 77.00 |
| Canopy Growth (CGC) | Canada | $0.450B | 0.00 |
| SNDL (SNDL) | Canada | $0.426B | 0.00 |
| Quanterix (QTRX) | United States | $0.371B | 0.00 |
| Evolus (EOLS) | United States | $0.324B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.309B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.307B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.287B | 22.85 |
| TerrAscend (TSNDF) | Canada | $0.244B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.240B | 141.33 |
| High Tide (HITI) | Canada | $0.220B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Organigram Global (OGI) | Canada | $0.215B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.212B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.197B | 0.00 |
| Accendra Health (ACH) | United States | $0.196B | 1.96 |
| Utah Medical Products (UTMD) | United States | $0.193B | 17.02 |
| Vireo Growth (VREOF) | United States | $0.193B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.158B | 0.00 |
| Apyx Medical (APYX) | United States | $0.149B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.147B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.147B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.117B | 0.00 |
| Fonar (FONR) | United States | $0.116B | 16.79 |
| Exagen (XGN) | United States | $0.109B | 0.00 |
| Biote (BTMD) | United States | $0.109B | 4.78 |
| MacroGenics (MGNX) | United States | $0.108B | 0.00 |
| Sharps Technology (STSS) | United States | $0.067B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 25.54 |
| Nephros (NEPH) | United States | $0.047B | 33.69 |
| Cytosorbents (CTSO) | United States | $0.043B | 0.00 |
| Veru (VERU) | United States | $0.039B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.037B | 0.00 |
| Modular Medical (MODD) | United States | $0.037B | 0.00 |
| United-Guardian (UG) | United States | $0.029B | 14.86 |
| Allurion Technologies (ALUR) | United States | $0.023B | 0.00 |
| Jin Medical (ZJYL) | China | $0.023B | 0.00 |
| Bonk (BNKK) | United States | $0.021B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.015B | 0.00 |
| INLIF (INLF) | China | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Flora Growth (FLGC) | United States | $0.007B | 0.00 |
| Agape ATP (ATPC) | $0.005B | 0.00 | |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |